2025

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

October 27, 2025 16:05 ET  | Source: Pulmonx Corporation Glen French, member of the Board of Directors and former Pulmonx…

2 months ago

CreatorWeek 2025 Launches in Macao, Offering a Unique, Vibrant Platform for Global Content Creators to Connect, Collaborate, and Innovate

MACAO, Oct. 27, 2025 /PRNewswire/ -- CreatorWeek Macao 2025, co-organized by Macao Government Tourism Office (MGTO) and Branded, with Adbeyond Group…

2 months ago

2025 Yangtze River Cultural Festival Opens in Zhangjiagang, Jiangsu

ZHANGJIAGANG, China, Oct. 27, 2025 /PRNewswire/ -- On October 24, the 2025 Yangtze River Cultural Festival formally began in Zhangjiagang, Jiangsu…

2 months ago

Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team

SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…

2 months ago

Indigenously Designed and Manufactured Laptops by Vyonix Launched at IMC 2025

GURUGRAM, India, Oct. 27, 2025 /PRNewswire/ -- India's 1st indigenously designed and manufactured Laptops, were launched at the India Mobile…

2 months ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

2 months ago

Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc

Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolismRobust…

2 months ago

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

October 25, 2025 11:01 ET  | Source: Cullinan Therapeutics, Inc. CLN-978 led to rapid and deep B cell depletion in…

2 months ago

No KYC Casinos 2025: Rakebit Rated as the Leading No Verification Online Casino

Baltimore, Maryland, Oct. 25, 2025 (GLOBE NEWSWIRE) --  RakeBit leads as no verification casinos rise, offering seamless play without ID…

2 months ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

2 months ago